| Michael S Hay, MD | |
|
1747 Village Park Dr, Orangeburg, SC 29118-2475 | |
| (803) 534-5700 | |
| (803) 534-5712 |
| Full Name | Michael S Hay |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 49 Years |
| Location | 1747 Village Park Dr, Orangeburg, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336145408 | NPI | - | NPPES |
| 340017157 | Other | SC | RAILROAD MEDICARE |
| 1900422 | Other | SC | PHP |
| 099958 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 9995 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Musc Medical Center | Charleston, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Musc Community Physicians | 6507260668 | 698 |
News Archive
NeuroVive Pharmaceutical AB, a leading mitochondrial medicine company, has recruited the first patient in a Phase IIa clinical trial to evaluate the company´s drug candidate NeuroSTAT® for the treatment of traumatic brain injury.
State governments, including California as well as others in Canada and the United Kingdom, pour hundreds of millions of taxpayer dollars into major motion pictures that depict smoking - leading to thousands of new teen smokers every year, a University of California, San Francisco (UCSF) researcher has found.
Clavis Pharma ASA announces that positive clinical data from its Phase II study with its lead cancer product candidate elacytarabine in patients with late-stage acute myeloid leukaemia (AML) was presented at the 51st American Society of Hematology (ASH) Annual Meeting in New Orleans, LA, USA.
A special focus on rogue proteins may hold future promise in stopping the progression of nerve cell destruction in people who have amyotrophic lateral sclerosis or frontotemporal dementia.
Veterans enrolled in the health care system of the Department of Veterans Affairs have begun to receive personalized booklets that explain their health care benefits and contain other useful information.
› Verified 3 days ago
| Entity Name | The Regional Medical Center Of Orangeburg And Calhoun Counties |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164496527 PECOS PAC ID: 8527970771 Enrollment ID: O20040202001087 |
News Archive
NeuroVive Pharmaceutical AB, a leading mitochondrial medicine company, has recruited the first patient in a Phase IIa clinical trial to evaluate the company´s drug candidate NeuroSTAT® for the treatment of traumatic brain injury.
State governments, including California as well as others in Canada and the United Kingdom, pour hundreds of millions of taxpayer dollars into major motion pictures that depict smoking - leading to thousands of new teen smokers every year, a University of California, San Francisco (UCSF) researcher has found.
Clavis Pharma ASA announces that positive clinical data from its Phase II study with its lead cancer product candidate elacytarabine in patients with late-stage acute myeloid leukaemia (AML) was presented at the 51st American Society of Hematology (ASH) Annual Meeting in New Orleans, LA, USA.
A special focus on rogue proteins may hold future promise in stopping the progression of nerve cell destruction in people who have amyotrophic lateral sclerosis or frontotemporal dementia.
Veterans enrolled in the health care system of the Department of Veterans Affairs have begun to receive personalized booklets that explain their health care benefits and contain other useful information.
› Verified 3 days ago
| Entity Name | Musc Community Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841878006 PECOS PAC ID: 6507260668 Enrollment ID: O20210811002388 |
News Archive
NeuroVive Pharmaceutical AB, a leading mitochondrial medicine company, has recruited the first patient in a Phase IIa clinical trial to evaluate the company´s drug candidate NeuroSTAT® for the treatment of traumatic brain injury.
State governments, including California as well as others in Canada and the United Kingdom, pour hundreds of millions of taxpayer dollars into major motion pictures that depict smoking - leading to thousands of new teen smokers every year, a University of California, San Francisco (UCSF) researcher has found.
Clavis Pharma ASA announces that positive clinical data from its Phase II study with its lead cancer product candidate elacytarabine in patients with late-stage acute myeloid leukaemia (AML) was presented at the 51st American Society of Hematology (ASH) Annual Meeting in New Orleans, LA, USA.
A special focus on rogue proteins may hold future promise in stopping the progression of nerve cell destruction in people who have amyotrophic lateral sclerosis or frontotemporal dementia.
Veterans enrolled in the health care system of the Department of Veterans Affairs have begun to receive personalized booklets that explain their health care benefits and contain other useful information.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael S Hay, MD 1747 Village Park Dr, Orangeburg, SC 29118-2475 Ph: (803) 534-5700 | Michael S Hay, MD 1747 Village Park Dr, Orangeburg, SC 29118-2475 Ph: (803) 534-5700 |
News Archive
NeuroVive Pharmaceutical AB, a leading mitochondrial medicine company, has recruited the first patient in a Phase IIa clinical trial to evaluate the company´s drug candidate NeuroSTAT® for the treatment of traumatic brain injury.
State governments, including California as well as others in Canada and the United Kingdom, pour hundreds of millions of taxpayer dollars into major motion pictures that depict smoking - leading to thousands of new teen smokers every year, a University of California, San Francisco (UCSF) researcher has found.
Clavis Pharma ASA announces that positive clinical data from its Phase II study with its lead cancer product candidate elacytarabine in patients with late-stage acute myeloid leukaemia (AML) was presented at the 51st American Society of Hematology (ASH) Annual Meeting in New Orleans, LA, USA.
A special focus on rogue proteins may hold future promise in stopping the progression of nerve cell destruction in people who have amyotrophic lateral sclerosis or frontotemporal dementia.
Veterans enrolled in the health care system of the Department of Veterans Affairs have begun to receive personalized booklets that explain their health care benefits and contain other useful information.
› Verified 3 days ago
Dr. Lawrence Phillips Thackston Jr., M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 646 Rivers Turn Road, Orangeburg, SC 29115 Phone: 803-536-0511 | |
Dr. William Walton Mims Jr., M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 1175 Cook Rd, Suite 310, Orangeburg, SC 29118 Phone: 803-534-4611 Fax: 803-534-7269 |